Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 trial in Japanese children with juvenile idiopathic arthritis evaluated safety, efficacy, and pharmacokinetics of adalimumab; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Juvenile Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2011-04-01